Mayne Pharma reported AUD1.24B in Ordinary Share Capital for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Ansell ANN:AU USD 743.8M 14.9M
Cochlear COH:AU AUD 1.28B 0
Ecofibre Ltd EOF:AU AUD 115.35M 524K
Healius Ltd HLS:AU AUD 2.42B 38.4M
Integral Diagnostics Ltd IDX:AU AUD 322.54M 88.01M
Medical Developments International Ltd MVP:AU AUD 76.99M 98K
Nanosonics Ltd NAN:AU AUD 113.85M 148K
Next Science Ltd NXS:AU USD 113.53M 28.24M
Polynovo Ltd PNV:AU AUD 139.43M 180K
Probiotec Ltd PBP:AU AUD 51.29M 600K
Ramsay Health Care RHC:AU AUD 2.2B 0
ResMed RMD:AU USD 586K 1000
Sigma Healthcare Ltd SIG:AU AUD 1.23B 4.93M
Sonic Healthcare SHL:AU AUD 3.87B 277.16M
Telix Pharmaceuticals Ltd TLX:AU AUD 344.11M 173.27M